Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
Overview
The Horizon Europe grant opportunity aims to support the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), focusing on enhancing international coordination in research responses to emerging infectious diseases. This initiative invites proposals under the HORIZON Coordination and Support Actions (CSA) using the HORIZON Lump Sum Grant mechanism. The submission deadline for proposals is September 16, 2025.
Eligible applicants include research institutions, universities, and consortia from EU Member States and Horizon Europe-associated countries. Notably, legal entities from the United States can also participate. The grant targets public health sectors, particularly in infectious disease research and pandemic preparedness.
The funding amount for this grant is estimated at €1–2 million, similar to other comparable CSA actions in the Horizon Europe framework. The application process is single-stage and encourages a collaborative approach among multiple organizations to support GloPID-R’s objectives.
Successful proposals should demonstrate strong administrative and technical capacity, enabling effective coordination of research responses during health emergencies. The expected outcomes include establishing a vibrant secretariat, developing a reliable framework for research response, and improving awareness among stakeholders regarding GloPID-R’s initiatives.
Given that the competition for funding is likely to be intense, with success rates estimated between 10% and 39%, applicants are encouraged to emphasize their capacity for collaboration and coordination within their proposals. Funding is provided as a lump sum, and there is no explicit co-funding requirement, although collaboration with international partners is integral to the initiative.
Overall, the grant seeks to enhance the capabilities of GloPID-R, ensuring that research efforts are well-coordinated and efficient in addressing the challenges posed by current and future health crises.
Eligible applicants include research institutions, universities, and consortia from EU Member States and Horizon Europe-associated countries. Notably, legal entities from the United States can also participate. The grant targets public health sectors, particularly in infectious disease research and pandemic preparedness.
The funding amount for this grant is estimated at €1–2 million, similar to other comparable CSA actions in the Horizon Europe framework. The application process is single-stage and encourages a collaborative approach among multiple organizations to support GloPID-R’s objectives.
Successful proposals should demonstrate strong administrative and technical capacity, enabling effective coordination of research responses during health emergencies. The expected outcomes include establishing a vibrant secretariat, developing a reliable framework for research response, and improving awareness among stakeholders regarding GloPID-R’s initiatives.
Given that the competition for funding is likely to be intense, with success rates estimated between 10% and 39%, applicants are encouraged to emphasize their capacity for collaboration and coordination within their proposals. Funding is provided as a lump sum, and there is no explicit co-funding requirement, although collaboration with international partners is integral to the initiative.
Overall, the grant seeks to enhance the capabilities of GloPID-R, ensuring that research efforts are well-coordinated and efficient in addressing the challenges posed by current and future health crises.
Detail
This is a Horizon Europe call for proposals under the Health cluster, specifically targeting "Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)". The call is for HORIZON Coordination and Support Actions (HORIZON-CSA) and uses the HORIZON Lump Sum Grant [HORIZON-AG-LS] funding mechanism. The call is currently open for submission with a deadline of September 16, 2025.
The primary goal is to support activities that contribute to tackling diseases and reducing the disease burden, with a focus on enhancing international research coordination for rapid responses to pandemics and severe epidemics. The expected outcomes include:
1. A dynamic and efficient secretariat supporting international research funders in coordinating rapid research responses.
2. A tested framework for effective research response, strengthening research preparedness for public health emergencies, including in areas like data sharing and clinical trial networks.
3. Improved awareness among research funders, policymakers, and the research community regarding GloPID-R's activities.
The scope of the call acknowledges the critical role of global collaboration in addressing emerging infectious diseases. GloPID-R, established in 2013, serves as a platform for infectious disease research funders to collaborate on tackling epidemics and pandemics. The call emphasizes the need for administrative and technical support to maintain and enhance GloPID-R's value.
Proposed activities should include:
1. Administrative and organizational support to the GloPID-R Board, in collaboration with the European Commission.
2. Strong scientific support through a transparent process, addressing topics requested by the GloPID-R Board, scientific advisors, or working groups.
3. Facilitation of GloPID-R working groups and scientific advisors, leveraging past experiences in infectious disease outbreak preparedness and response.
4. Management of information dissemination and communication among stakeholders.
5. External communications activities, including website, newsletter, and social media management.
6. Submission of an annual work plan to the Commission, based on the GloPID-R annual meeting.
7. Ensuring adaptability to rapidly evolving situations, guided by the GloPID-R Board.
The admissibility conditions, proposal page limits, and layout are detailed in Annex A and Annex E of the Horizon Europe Work Programme General Annexes and Part B of the Application Form. Eligible countries are listed in Annex B of the Work Programme General Annexes. Notably, legal entities from the United States of America are exceptionally eligible for Union funding under this call. Project coordinators must be legal entities established in an EU Member State or Associated Country. Projects utilizing satellite-based earth observation data must use Copernicus and/or Galileo/EGNOS.
Financial and operational capacity and exclusion criteria are described in Annex C of the Work Programme General Annexes. Evaluation and award criteria, scoring, and thresholds are in Annex D, with thresholds of 4 for Excellence, Impact, and Implementation, and a cumulative threshold of 12. Submission and evaluation processes are detailed in Annex F and the Online Manual. The indicative timeline for evaluation and grant agreement is also in Annex F.
Eligible costs will be reimbursed as a lump sum, as defined in the Decision of 7 July 2021. Legal and financial aspects are covered in Annex G of the Work Programme General Annexes. Specific conditions are described in the specific topic of the Work Programme.
Application and evaluation forms are available in the Submission System. Guidance documents include the HE Programme Guide, Model Grant Agreement (MGA), Lump Sum MGA, call-specific instructions, and a detailed budget table. Additional documents listed are the HE Main Work Programme 2025 (General Introduction, Health, and General Annexes), HE Framework Programme 2021/695, HE Specific Programme Decision 2021/764, EU Financial Regulation 2024/2509, the Decision authorising the use of lump sum contributions, Rules for Legal Entity Validation, the EU Grants AGA, and the Funding & Tenders Portal resources.
There are 32 partner search announcements available.
The budget overview lists several topics under the Horizon Health call for 2025, including:
HORIZON-HLTH-2025-01-CARE-01: Budget of EUR 40,000,000, contributions of EUR 15,000,000 to EUR 20,000,000, 2 grants
HORIZON-HLTH-2025-01-DISEASE-01: Budget of EUR 45,000,000, contributions around EUR 15,000,000, 3 grants
HORIZON-HLTH-2025-01-DISEASE-03: Budget of EUR 50,000,000, contributions around EUR 10,000,000, 5 grants
HORIZON-HLTH-2025-01-DISEASE-04: Budget of EUR 35,000,000, contributions of EUR 6,000,000 to EUR 8,000,000, 5 grants
HORIZON-HLTH-2025-01-DISEASE-05: Budget of EUR 2,000,000, contributions around EUR 2,000,000, 1 grant
HORIZON-HLTH-2025-01-DISEASE-06: Budget of EUR 20,000,000, contributions of EUR 3,000,000 to EUR 4,000,000, 5 grants
HORIZON-HLTH-2025-01-DISEASE-07: Budget of EUR 30,000,000, contributions around EUR 6,000,000, 5 grants
HORIZON-HLTH-2025-01-IND-01: Budget of EUR 40,000,000, contributions of EUR 6,000,000 to EUR 8,000,000, 5 grants
HORIZON-HLTH-2025-01-IND-02: Budget of EUR 4,000,000, contributions around EUR 4,000,000, 1 grant
HORIZON-HLTH-2025-01-TOOL-01: Budget of EUR 50,000,000, contributions of EUR 8,000,000 to EUR 10,000,000, 5 grants
HORIZON-HLTH-2025-01-TOOL-02: Budget of EUR 40,000,000, contributions of EUR 9,000,000 to EUR 13,000,000, 3 grants
HORIZON-HLTH-2025-01-TOOL-03: Budget of EUR 50,000,000, contributions of EUR 15,000,000 to EUR 17,000,000, 3 grants
HORIZON-HLTH-2025-01-TOOL-05: Budget of EUR 80,000,000, contributions of EUR 4,000,000 to EUR 8,000,000, 10 grants
This funding opportunity aims to bolster the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) by providing financial support for its administrative and scientific activities. It seeks to improve international coordination in responding to infectious disease outbreaks, enhance research preparedness, and ensure effective communication among stakeholders. The funding will be distributed as a lump sum, and eligible applicants should be legal entities from EU member states or associated countries, with exceptions made for US entities. The call encourages projects that can provide administrative, organizational, and scientific support to GloPID-R, facilitate the work of its groups, manage information dissemination, and ensure adaptability in rapidly evolving situations.
The primary goal is to support activities that contribute to tackling diseases and reducing the disease burden, with a focus on enhancing international research coordination for rapid responses to pandemics and severe epidemics. The expected outcomes include:
1. A dynamic and efficient secretariat supporting international research funders in coordinating rapid research responses.
2. A tested framework for effective research response, strengthening research preparedness for public health emergencies, including in areas like data sharing and clinical trial networks.
3. Improved awareness among research funders, policymakers, and the research community regarding GloPID-R's activities.
The scope of the call acknowledges the critical role of global collaboration in addressing emerging infectious diseases. GloPID-R, established in 2013, serves as a platform for infectious disease research funders to collaborate on tackling epidemics and pandemics. The call emphasizes the need for administrative and technical support to maintain and enhance GloPID-R's value.
Proposed activities should include:
1. Administrative and organizational support to the GloPID-R Board, in collaboration with the European Commission.
2. Strong scientific support through a transparent process, addressing topics requested by the GloPID-R Board, scientific advisors, or working groups.
3. Facilitation of GloPID-R working groups and scientific advisors, leveraging past experiences in infectious disease outbreak preparedness and response.
4. Management of information dissemination and communication among stakeholders.
5. External communications activities, including website, newsletter, and social media management.
6. Submission of an annual work plan to the Commission, based on the GloPID-R annual meeting.
7. Ensuring adaptability to rapidly evolving situations, guided by the GloPID-R Board.
The admissibility conditions, proposal page limits, and layout are detailed in Annex A and Annex E of the Horizon Europe Work Programme General Annexes and Part B of the Application Form. Eligible countries are listed in Annex B of the Work Programme General Annexes. Notably, legal entities from the United States of America are exceptionally eligible for Union funding under this call. Project coordinators must be legal entities established in an EU Member State or Associated Country. Projects utilizing satellite-based earth observation data must use Copernicus and/or Galileo/EGNOS.
Financial and operational capacity and exclusion criteria are described in Annex C of the Work Programme General Annexes. Evaluation and award criteria, scoring, and thresholds are in Annex D, with thresholds of 4 for Excellence, Impact, and Implementation, and a cumulative threshold of 12. Submission and evaluation processes are detailed in Annex F and the Online Manual. The indicative timeline for evaluation and grant agreement is also in Annex F.
Eligible costs will be reimbursed as a lump sum, as defined in the Decision of 7 July 2021. Legal and financial aspects are covered in Annex G of the Work Programme General Annexes. Specific conditions are described in the specific topic of the Work Programme.
Application and evaluation forms are available in the Submission System. Guidance documents include the HE Programme Guide, Model Grant Agreement (MGA), Lump Sum MGA, call-specific instructions, and a detailed budget table. Additional documents listed are the HE Main Work Programme 2025 (General Introduction, Health, and General Annexes), HE Framework Programme 2021/695, HE Specific Programme Decision 2021/764, EU Financial Regulation 2024/2509, the Decision authorising the use of lump sum contributions, Rules for Legal Entity Validation, the EU Grants AGA, and the Funding & Tenders Portal resources.
There are 32 partner search announcements available.
The budget overview lists several topics under the Horizon Health call for 2025, including:
HORIZON-HLTH-2025-01-CARE-01: Budget of EUR 40,000,000, contributions of EUR 15,000,000 to EUR 20,000,000, 2 grants
HORIZON-HLTH-2025-01-DISEASE-01: Budget of EUR 45,000,000, contributions around EUR 15,000,000, 3 grants
HORIZON-HLTH-2025-01-DISEASE-03: Budget of EUR 50,000,000, contributions around EUR 10,000,000, 5 grants
HORIZON-HLTH-2025-01-DISEASE-04: Budget of EUR 35,000,000, contributions of EUR 6,000,000 to EUR 8,000,000, 5 grants
HORIZON-HLTH-2025-01-DISEASE-05: Budget of EUR 2,000,000, contributions around EUR 2,000,000, 1 grant
HORIZON-HLTH-2025-01-DISEASE-06: Budget of EUR 20,000,000, contributions of EUR 3,000,000 to EUR 4,000,000, 5 grants
HORIZON-HLTH-2025-01-DISEASE-07: Budget of EUR 30,000,000, contributions around EUR 6,000,000, 5 grants
HORIZON-HLTH-2025-01-IND-01: Budget of EUR 40,000,000, contributions of EUR 6,000,000 to EUR 8,000,000, 5 grants
HORIZON-HLTH-2025-01-IND-02: Budget of EUR 4,000,000, contributions around EUR 4,000,000, 1 grant
HORIZON-HLTH-2025-01-TOOL-01: Budget of EUR 50,000,000, contributions of EUR 8,000,000 to EUR 10,000,000, 5 grants
HORIZON-HLTH-2025-01-TOOL-02: Budget of EUR 40,000,000, contributions of EUR 9,000,000 to EUR 13,000,000, 3 grants
HORIZON-HLTH-2025-01-TOOL-03: Budget of EUR 50,000,000, contributions of EUR 15,000,000 to EUR 17,000,000, 3 grants
HORIZON-HLTH-2025-01-TOOL-05: Budget of EUR 80,000,000, contributions of EUR 4,000,000 to EUR 8,000,000, 10 grants
This funding opportunity aims to bolster the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) by providing financial support for its administrative and scientific activities. It seeks to improve international coordination in responding to infectious disease outbreaks, enhance research preparedness, and ensure effective communication among stakeholders. The funding will be distributed as a lump sum, and eligible applicants should be legal entities from EU member states or associated countries, with exceptions made for US entities. The call encourages projects that can provide administrative, organizational, and scientific support to GloPID-R, facilitate the work of its groups, manage information dissemination, and ensure adaptability in rapidly evolving situations.
Find a Consultant to Support You
Breakdown
Eligible Applicant Types: The eligible applicant types for this opportunity include legal entities such as research organizations, universities, and other entities capable of providing administrative and technical support. Coordinators of projects must be legal entities established in an EU Member State or Associated Country. In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding.
Funding Type: The funding type for this opportunity is a grant, specifically a HORIZON Coordination and Support Action (HORIZON-CSA) with a HORIZON Lump Sum Grant [HORIZON-AG-LS] mechanism. Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025).
Consortium Requirement: While the information doesn't explicitly state a consortium is required, the nature of the activities suggests that a single applicant capable of providing comprehensive administrative and technical support to GloPID-R could be eligible. However, collaboration and coordination are central to GloPID-R's mission, so proposals that demonstrate a network or collaborative approach may be viewed favorably.
Beneficiary Scope (Geographic Eligibility): Eligible countries are described in Annex B of the Work Programme General Annexes. Coordinators of projects must be legal entities established in an EU Member State or Associated Country. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding.
Target Sector: The target sector for this program is health, specifically focusing on tackling diseases and reducing disease burden, infectious disease research, epidemic and pandemic preparedness, data sharing, social science, and clinical trial networks.
Mentioned Countries: The United States of America, EU Member States, and Associated Countries are explicitly mentioned.
Project Stage: The project stage is focused on coordination and support actions, implying activities that enable or contribute to expected outcomes related to tackling diseases and reducing disease burden. This includes providing administrative and technical support, facilitating collaboration, managing information dissemination, and ensuring adaptability to evolving situations.
Funding Amount: The budget for the HORIZON-HLTH-2025-01-DISEASE-05 topic is EUR 2,000,000, and it is expected that one grant will be awarded. Other topics listed in the budget overview have varying budgets and indicative numbers of grants. HORIZON-HLTH-2025-01-CARE-01 has a budget of 40,000,000 EUR and an indicative number of 2 grants with contributions from 15,000,000 to 20,000,000 EUR. HORIZON-HLTH-2025-01-DISEASE-01 has a budget of 45,000,000 EUR and an indicative number of 3 grants with contributions around 15,000,000 EUR. HORIZON-HLTH-2025-01-DISEASE-03 has a budget of 50,000,000 EUR and an indicative number of 5 grants with contributions around 10,000,000 EUR. HORIZON-HLTH-2025-01-DISEASE-04 has a budget of 35,000,000 EUR and an indicative number of 5 grants with contributions from 6,000,000 to 8,000,000 EUR. HORIZON-HLTH-2025-01-DISEASE-06 has a budget of 20,000,000 EUR and an indicative number of 5 grants with contributions from 3,000,000 to 4,000,000 EUR. HORIZON-HLTH-2025-01-DISEASE-07 has a budget of 30,000,000 EUR and an indicative number of 5 grants with contributions around 6,000,000 EUR. HORIZON-HLTH-2025-01-IND-01 has a budget of 40,000,000 EUR and an indicative number of 5 grants with contributions from 6,000,000 to 8,000,000 EUR. HORIZON-HLTH-2025-01-IND-02 has a budget of 4,000,000 EUR and an indicative number of 1 grant with contributions around 4,000,000 EUR. HORIZON-HLTH-2025-01-TOOL-01 has a budget of 50,000,000 EUR and an indicative number of 5 grants with contributions from 8,000,000 to 10,000,000 EUR. HORIZON-HLTH-2025-01-TOOL-02 has a budget of 40,000,000 EUR and an indicative number of 3 grants with contributions from 9,000,000 to 13,000,000 EUR. HORIZON-HLTH-2025-01-TOOL-03 has a budget of 50,000,000 EUR and an indicative number of 3 grants with contributions from 15,000,000 to 17,000,000 EUR. HORIZON-HLTH-2025-01-TOOL-05 has a budget of 80,000,000 EUR and an indicative number of 10 grants with contributions from 4,000,000 to 8,000,000 EUR.
Application Type: The application type is an open call, with a single-stage submission process.
Nature of Support: The beneficiaries will receive money in the form of a lump sum grant.
Application Stages: The application process is single-stage.
Success Rates: Success rates are not explicitly mentioned, but the indicative number of grants for each topic provides some insight into the potential competitiveness. For HORIZON-HLTH-2025-01-DISEASE-05, with one grant expected and a budget of EUR 2,000,000, the competition is likely to be high.
Co-funding Requirement: The information does not explicitly mention a co-funding requirement.
This Horizon Europe call, HORIZON-HLTH-2025-01-DISEASE-05, focuses on providing support for the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). The primary goal is to bolster international coordination in research efforts to combat epidemics and pandemics. The funding will be allocated as a lump sum grant to a project that can effectively provide administrative, organizational, and scientific support to GloPID-R. This includes managing communication, facilitating working groups, and ensuring adaptability to rapidly evolving health crises. Eligible applicants are legal entities from EU Member States, associated countries, and, exceptionally, the United States. The call aims to enhance global research preparedness and response to public health emergencies, ensuring that research funders, policymakers, and the research community are well-informed and coordinated in their efforts. The call is a single-stage submission process with a deadline of September 16, 2025.
Funding Type: The funding type for this opportunity is a grant, specifically a HORIZON Coordination and Support Action (HORIZON-CSA) with a HORIZON Lump Sum Grant [HORIZON-AG-LS] mechanism. Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025).
Consortium Requirement: While the information doesn't explicitly state a consortium is required, the nature of the activities suggests that a single applicant capable of providing comprehensive administrative and technical support to GloPID-R could be eligible. However, collaboration and coordination are central to GloPID-R's mission, so proposals that demonstrate a network or collaborative approach may be viewed favorably.
Beneficiary Scope (Geographic Eligibility): Eligible countries are described in Annex B of the Work Programme General Annexes. Coordinators of projects must be legal entities established in an EU Member State or Associated Country. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding.
Target Sector: The target sector for this program is health, specifically focusing on tackling diseases and reducing disease burden, infectious disease research, epidemic and pandemic preparedness, data sharing, social science, and clinical trial networks.
Mentioned Countries: The United States of America, EU Member States, and Associated Countries are explicitly mentioned.
Project Stage: The project stage is focused on coordination and support actions, implying activities that enable or contribute to expected outcomes related to tackling diseases and reducing disease burden. This includes providing administrative and technical support, facilitating collaboration, managing information dissemination, and ensuring adaptability to evolving situations.
Funding Amount: The budget for the HORIZON-HLTH-2025-01-DISEASE-05 topic is EUR 2,000,000, and it is expected that one grant will be awarded. Other topics listed in the budget overview have varying budgets and indicative numbers of grants. HORIZON-HLTH-2025-01-CARE-01 has a budget of 40,000,000 EUR and an indicative number of 2 grants with contributions from 15,000,000 to 20,000,000 EUR. HORIZON-HLTH-2025-01-DISEASE-01 has a budget of 45,000,000 EUR and an indicative number of 3 grants with contributions around 15,000,000 EUR. HORIZON-HLTH-2025-01-DISEASE-03 has a budget of 50,000,000 EUR and an indicative number of 5 grants with contributions around 10,000,000 EUR. HORIZON-HLTH-2025-01-DISEASE-04 has a budget of 35,000,000 EUR and an indicative number of 5 grants with contributions from 6,000,000 to 8,000,000 EUR. HORIZON-HLTH-2025-01-DISEASE-06 has a budget of 20,000,000 EUR and an indicative number of 5 grants with contributions from 3,000,000 to 4,000,000 EUR. HORIZON-HLTH-2025-01-DISEASE-07 has a budget of 30,000,000 EUR and an indicative number of 5 grants with contributions around 6,000,000 EUR. HORIZON-HLTH-2025-01-IND-01 has a budget of 40,000,000 EUR and an indicative number of 5 grants with contributions from 6,000,000 to 8,000,000 EUR. HORIZON-HLTH-2025-01-IND-02 has a budget of 4,000,000 EUR and an indicative number of 1 grant with contributions around 4,000,000 EUR. HORIZON-HLTH-2025-01-TOOL-01 has a budget of 50,000,000 EUR and an indicative number of 5 grants with contributions from 8,000,000 to 10,000,000 EUR. HORIZON-HLTH-2025-01-TOOL-02 has a budget of 40,000,000 EUR and an indicative number of 3 grants with contributions from 9,000,000 to 13,000,000 EUR. HORIZON-HLTH-2025-01-TOOL-03 has a budget of 50,000,000 EUR and an indicative number of 3 grants with contributions from 15,000,000 to 17,000,000 EUR. HORIZON-HLTH-2025-01-TOOL-05 has a budget of 80,000,000 EUR and an indicative number of 10 grants with contributions from 4,000,000 to 8,000,000 EUR.
Application Type: The application type is an open call, with a single-stage submission process.
Nature of Support: The beneficiaries will receive money in the form of a lump sum grant.
Application Stages: The application process is single-stage.
Success Rates: Success rates are not explicitly mentioned, but the indicative number of grants for each topic provides some insight into the potential competitiveness. For HORIZON-HLTH-2025-01-DISEASE-05, with one grant expected and a budget of EUR 2,000,000, the competition is likely to be high.
Co-funding Requirement: The information does not explicitly mention a co-funding requirement.
This Horizon Europe call, HORIZON-HLTH-2025-01-DISEASE-05, focuses on providing support for the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). The primary goal is to bolster international coordination in research efforts to combat epidemics and pandemics. The funding will be allocated as a lump sum grant to a project that can effectively provide administrative, organizational, and scientific support to GloPID-R. This includes managing communication, facilitating working groups, and ensuring adaptability to rapidly evolving health crises. Eligible applicants are legal entities from EU Member States, associated countries, and, exceptionally, the United States. The call aims to enhance global research preparedness and response to public health emergencies, ensuring that research funders, policymakers, and the research community are well-informed and coordinated in their efforts. The call is a single-stage submission process with a deadline of September 16, 2025.
Short Summary
Impact This grant aims to strengthen the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) by enhancing international coordination in research efforts to combat epidemics and pandemics. | Impact | This grant aims to strengthen the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) by enhancing international coordination in research efforts to combat epidemics and pandemics. |
Applicant Eligible applicants include research institutions, universities, and consortia with expertise in infectious disease research and global health coordination. | Applicant | Eligible applicants include research institutions, universities, and consortia with expertise in infectious disease research and global health coordination. |
Developments The funding will support activities that contribute to tackling diseases and reducing the disease burden, specifically focusing on emerging infectious disease preparedness and research coordination. | Developments | The funding will support activities that contribute to tackling diseases and reducing the disease burden, specifically focusing on emerging infectious disease preparedness and research coordination. |
Applicant Type This funding is designed for research institutions, universities, and international consortia involved in infectious disease research. | Applicant Type | This funding is designed for research institutions, universities, and international consortia involved in infectious disease research. |
Consortium A consortium is required, as proposals must involve multiple organizations from different countries, reflecting GloPID-R’s collaborative nature. | Consortium | A consortium is required, as proposals must involve multiple organizations from different countries, reflecting GloPID-R’s collaborative nature. |
Funding Amount The funding amount is expected to be around €1-2 million, based on similar Coordination and Support Actions in Horizon Europe. | Funding Amount | The funding amount is expected to be around €1-2 million, based on similar Coordination and Support Actions in Horizon Europe. |
Countries Eligible countries include EU Member States, Horizon Europe-associated countries, and exceptionally, the United States of America. | Countries | Eligible countries include EU Member States, Horizon Europe-associated countries, and exceptionally, the United States of America. |
Industry The funding targets the health sector, specifically public health and infectious diseases, with a focus on research coordination and preparedness. | Industry | The funding targets the health sector, specifically public health and infectious diseases, with a focus on research coordination and preparedness. |
Update Log
No updates recorded yet.
Discover with AI
Let our intelligent agent help you find the perfect funding opportunities tailored to your needs.
Try AI Agent →
EU Grant Database
Explore European funding opportunities in our comprehensive, up-to-date collection.
Browse Database →
Stay Informed
Get notified when grants change, deadlines approach, or new opportunities match your interests.
Configure Notifications →
Track Your Favorites
Follow grants you're interested in and keep them organized in one place. Get updates on changes and deadlines.
Use the Follow button above ↑
European Partnership for Pandemic Preparedness (Phase 2)
Call for ProposalForthcoming
The European Partnership for Pandemic Preparedness (Phase 2) is a funding opportunity under the Horizon Europe program, specifically for the call HORIZON-HLTH-2026-03-DISEASE-13. This initiative...
April 13th, 2027
Development of novel vaccines for viral pathogens with epidemic potential
Call for ProposalForthcoming
The EU grant opportunity focuses on the development of novel vaccines for viral pathogens with epidemic potential, identified as HORIZON-HLTH-2026-01-DISEASE-04. This call encourages applications...
April 16th, 2026
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Call for ProposalForthcoming
The Horizon Europe grant opportunity HORIZON-HLTH-2027-01-DISEASE-05 focuses on developing novel small molecule antiviral therapeutics for pathogens with epidemic potential. This call encourages...
April 13th, 2027
Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Call for ProposalForthcoming
The Horizon Europe grant opportunity, HORIZON-HLTH-2026-01-DISEASE-09, aims to fund implementation research addressing chronic non-communicable diseases (NCDs) through a multisectoral approach. Total...
April 16th, 2026
Understanding how infections foster and induce non-communicable diseases
Call for ProposalOpen
The HORIZON-JU-IHI-2025-11-02-two-stage call is part of the Innovative Health Initiative (IHI) under the Horizon Europe programme, focusing on the relationships between infectious agents and...
April 29th, 2026
Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Call for ProposalForthcoming
The Horizon Europe call HORIZON-HLTH-2027-01-DISEASE-07 focuses on the development of monoclonal antibodies aimed at preventing and treating infections caused by Filo-, Nairo-, Phenui-, Picorna-, and...
April 13th, 2027
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Call for ProposalForthcoming
The EU funding opportunity, HORIZON-HLTH-2027-01-DISEASE-06, focuses on the development of monoclonal antibodies to prevent and treat infections from Flaviviruses, targeting diseases like Dengue,...
April 13th, 2027
Strengthening the international dimension of ESFRI and/or ERIC research infrastructures
Call for ProposalForthcoming
This summary outlines the Horizon Europe funding opportunity, specifically aimed at strengthening the international dimension of ESFRI (European Strategy Forum on Research Infrastructures) and ERIC...
June 16th, 2026
Support for a multilateral initiative on climate change and health research
Call for ProposalForthcoming
The Horizon Europe call for proposals, specifically HORIZON-HLTH-2026-01-ENVHLTH-05, focuses on supporting the establishment of an international multilateral initiative aimed at addressing the...
April 16th, 2026
Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices
Call for ProposalOpen
The grant opportunity titled "Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (‘breakthrough’) devices" is part of Horizon Europe's Health...
April 16th, 2026
MSCA Staff Exchanges 2026
Call for ProposalOpen
The HORIZON-MSCA-2026-SE-01-01 call, part of the Marie Skłodowska-Curie Actions (MSCA) under the Horizon Europe program, is focused on facilitating international, inter-sectoral, and...
April 16th, 2026
Emerging and future risks to plant health
Call for ProposalOpen
The European Union is offering a funding opportunity through Horizon Europe focused on emerging and future risks to plant health, specifically under the topic HORIZON-CL6-2025-02-FARM2FORK-01, which...
February 17th, 2026